semaglutide and retinal detachment GLP-1 Drugs Diabetic Eye Disease: Ozempic, Semaglutide, and Retinopathy Risk Ozempic Blindness Lawsuit [2026 Update]

Age, baseline hydration status, and medication combinations can all influence individual susceptibility

GLP-1 therapy has been linked to improved inflammatory markers (like Hs-CRP), metabolic markers (like HbA1C), and lipid/cholesterol markers (like HDL and LDL)

This means that the drugs will usually be reserved for certain diabetic patients, with their GPs approval

BPC 157 activated the Src-Cav-1-eNOS signal pathway and reduced eNOS/Cav-1 binding in vascular endothelial cells It is known that phosphorylation of Src can promote Cav-1 activation and subsequent endocytosis of tyrosine kinase receptors and eNOS activation 20,24

Take a patient-first approach: Consider the full patient journey across medications and platforms, and prioritize simplicity, coordination, and continuity of care to avoid creating a fragmented experience